Atomistry » Nickel » PDB 5mdk-5ph1 » 5om8
Atomistry »
  Nickel »
    PDB 5mdk-5ph1 »
      5om8 »

Nickel in PDB 5om8: Crystal Form 2 of ALPHA1-Antichymotrypsin Variant Dbs-II-Allo: An Allosterically Modulated Drug-Binding Serpin For Doxorubicin

Protein crystallography data

The structure of Crystal Form 2 of ALPHA1-Antichymotrypsin Variant Dbs-II-Allo: An Allosterically Modulated Drug-Binding Serpin For Doxorubicin, PDB code: 5om8 was solved by K.Schmidt, Y.A.Muller, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 40.58 / 2.20
Space group P 31 2 1
Cell size a, b, c (Å), α, β, γ (°) 84.542, 84.542, 97.519, 90.00, 90.00, 120.00
R / Rfree (%) 18.5 / 24.2

Other elements in 5om8:

The structure of Crystal Form 2 of ALPHA1-Antichymotrypsin Variant Dbs-II-Allo: An Allosterically Modulated Drug-Binding Serpin For Doxorubicin also contains other interesting chemical elements:

Chlorine (Cl) 1 atom

Nickel Binding Sites:

The binding sites of Nickel atom in the Crystal Form 2 of ALPHA1-Antichymotrypsin Variant Dbs-II-Allo: An Allosterically Modulated Drug-Binding Serpin For Doxorubicin (pdb code 5om8). This binding sites where shown within 5.0 Angstroms radius around Nickel atom.
In total only one binding site of Nickel was determined in the Crystal Form 2 of ALPHA1-Antichymotrypsin Variant Dbs-II-Allo: An Allosterically Modulated Drug-Binding Serpin For Doxorubicin, PDB code: 5om8:

Nickel binding site 1 out of 1 in 5om8

Go back to Nickel Binding Sites List in 5om8
Nickel binding site 1 out of 1 in the Crystal Form 2 of ALPHA1-Antichymotrypsin Variant Dbs-II-Allo: An Allosterically Modulated Drug-Binding Serpin For Doxorubicin


Mono view


Stereo pair view

A full contact list of Nickel with other atoms in the Ni binding site number 1 of Crystal Form 2 of ALPHA1-Antichymotrypsin Variant Dbs-II-Allo: An Allosterically Modulated Drug-Binding Serpin For Doxorubicin within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Ni503

b:32.0
occ:1.00
SG A:CYS238 2.2 40.6 1.0
CB A:CYS238 3.3 36.2 1.0
C A:CYS238 3.5 34.5 1.0
C A:THR239 3.6 34.7 1.0
O A:CYS238 3.6 35.0 1.0
N A:VAL240 3.6 33.8 1.0
CZ A:PHE276 3.7 32.9 1.0
N A:THR239 3.7 31.8 1.0
CB A:VAL240 3.8 36.7 1.0
CG1 A:VAL240 3.8 38.2 1.0
CE1 A:PHE276 3.8 34.2 1.0
O A:THR239 3.9 32.9 1.0
CA A:THR239 3.9 37.2 1.0
CA A:CYS238 4.0 33.9 1.0
CB A:ASP233 4.0 44.5 1.0
CE2 A:PHE276 4.1 35.7 1.0
CA A:VAL240 4.2 33.2 1.0
CG2 A:ILE254 4.3 29.9 1.0
CD1 A:PHE276 4.4 35.9 1.0
O A:PHE231 4.7 42.8 1.0
CD2 A:PHE276 4.7 37.8 1.0
N A:CYS238 4.8 36.8 1.0
N A:ASP233 4.8 46.6 1.0
CG A:PHE276 4.9 38.1 1.0
OD2 A:ASP233 5.0 46.9 1.0
CG A:ASP233 5.0 45.1 1.0

Reference:

K.Schmidt, B.R.Gardill, A.Kern, P.Kirchweger, M.Borsch, Y.A.Muller. Design of An Allosterically Modulated Doxycycline and Doxorubicin Drug-Binding Protein. Proc. Natl. Acad. Sci. V. 115 5744 2018U.S.A..
ISSN: ESSN 1091-6490
PubMed: 29760101
DOI: 10.1073/PNAS.1716666115
Page generated: Wed Dec 16 01:42:19 2020

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy